Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, with Dapagliflozin and Ipragliflozin.

Choi, Min-Koo; Nam, So Jeong; Ji, Hye-Young; Park, Mi Jie; Choi, Ji-Soo; Song, Im-Sook

Choi, Min-Koo; Nam, So Jeong; Ji, Hye-Young; Park, Mi Jie; Choi, Ji-Soo; Song, Im-Sook.

Afiliação

Choi MK; College of Pharmacy, Dankook University, Cheon-an 31116, Korea.
Nam SJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Korea.
Ji HY; Life Science Institute, Daewoong Pharmaceutical, Yongin, Gyeonggido 17028, Korea.
Park MJ; Life Science Institute, Daewoong Pharmaceutical, Yongin, Gyeonggido 17028, Korea.
Choi JS; Life Science Institute, Daewoong Pharmaceutical, Yongin, Gyeonggido 17028, Korea.
Song IS; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Korea.

Pharmaceutics ; 12(3)2020 Mar 15.

Article em En | MEDLINE | ID: mdl-32183468

Palavras-chave

DWP16001; inhibition mode; kidney distribution; sodium-glucose cotransporter 2 (SGLT2) inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2020 Tipo de documento: Article